Evidence map›Paper›PMID 26690544›Full record

ArticleOncogenesis2015

CancerNet: a database for decoding multilevel molecular interactions across diverse cancer types.

X Meng, J Wang, C Yuan, X Li, Y Zhou, R Hofestädt, M Chen

Abstract read
In one paragraph

Article in Oncogenesis, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Review
  2. Article
  3. Bioinformatics Methods for Modeling microRNA Regulatory Networks in Cancer.Advances in experimental medicine and biology · 2022
    Article
  4. Article
  5. Article
  6. PINA 3.0: mining cancer interactome.Nucleic acids research · 2021
    Article
  7. Article
  8. Frontiers in pharmacology · 2019
    Review
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

X MengDepartment of Bioinformatics, College of Life Sciences, Zhejiang University, Hangzhou, China.
J WangDepartment of Bioinformatics, College of Life Sciences, Zhejiang University, Hangzhou, China.
C YuanDepartment of Bioinformatics, College of Life Sciences, Zhejiang University, Hangzhou, China.
X LiDepartment of Bioinformatics, College of Life Sciences, Zhejiang University, Hangzhou, China.
Y ZhouDepartment of Bioinformatics, College of Life Sciences, Zhejiang University, Hangzhou, China.
R HofestädtDepartment of Bioinformatics and Medical Informatics, Faculty of Technology, Bielefeld University, Bielefeld, Germany.
M ChenDepartment of Bioinformatics, College of Life Sciences, Zhejiang University, Hangzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Protein-protein interactions (PPIs) and microRNA (miRNA)-target interactions are important for deciphering the mechanisms of tumorigenesis. However, current PPI databases do not support cancer-specific analysis. Also, no available databases can be used to retrieve cancer-associated miRNA-target interactions. As the pathogenesis of human cancers is affected by several miRNAs rather than a single miRNA, it is needed to uncover miRNA synergism in a systems level. Here for each cancer type, we constructed a miRNA-miRNA functionally synergistic network based on the functions of miRNA targets and their topological features in that cancer PPI network. And for the first time, we report the cancer-specific database CancerNet (http://bis.zju.edu.cn/CancerNet), which contains information about PPIs, miRNA-target interactions and functionally synergistic miRNA-miRNA pairs across 33 human cancer types. In addition, PPI information across 33 main normal tissues and cell types are included. Flexible query methods are allowed to retrieve cancer molecular interactions. Network viewer can be used to visualize interactions that users are interested in. Enrichment analysis tool was designed to detect significantly overrepresented Gene Ontology categories of miRNA targets. Thus, CancerNet serves as a comprehensive platform for assessing the roles of proteins and miRNAs, as well as their interactions across human cancers.

Identifiers

PMID26690544
PMCPMC4688397

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.